Millennium Management’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,577
| Closed | -$158K | – | 6401 |
|
|
2024
Q4 | $158K | Buy |
+14,577
| New | +$188K | ﹤0.01% | 5380 |
|
|
2023
Q4 | – | Sell |
-1,656
| Closed | -$6.74K | – | 6544 |
|
|
2023
Q3 | $6.74K | Buy |
1,656
+861
| +108% | +$8.27K | ﹤0.01% | 5828 |
|
|
2023
Q2 | $13.1K | Sell |
795
-497
| -38% | -$12.5K | ﹤0.01% | 5714 |
|
|
2023
Q1 | $39K | Buy |
+1,292
| New | +$28.3K | ﹤0.01% | 5696 |
|
|
2022
Q4 | – | Sell |
-843
| Closed | -$19K | – | 7060 |
|
|
2022
Q3 | $19K | Sell |
843
-209
| -20% | -$6.2K | ﹤0.01% | 6475 |
|
|
2022
Q2 | $29K | Buy |
+1,052
| New | +$40.9K | ﹤0.01% | 6383 |
|
|
2022
Q1 | – | Sell |
-1,125
| Closed | -$77K | – | 7496 |
|
|
2021
Q4 | $77K | Sell |
1,125
-1,111
| -50% | -$153K | ﹤0.01% | 6354 |
|
|
2021
Q3 | $421K | Buy |
+2,236
| New | +$435K | ﹤0.01% | 5504 |
|
|
2020
Q4 | – | Sell |
-70
| Closed | -$22 | – | 5593 |
|
|
2020
Q3 | $22 | Sell |
70
-7
| -9% | -$2.37K | ﹤0.01% | 4344 |
|
|
2020
Q2 | $27K | Sell |
77
-19
| -20% | -$7.58K | ﹤0.01% | 4079 |
|
|
2020
Q1 | $99K | Buy |
+96
| New | +$140K | ﹤0.01% | 3552 |
|
|
2019
Q2 | – | Sell |
-256
| Closed | -$749K | – | 4459 |
|
|
2019
Q1 | $749K | Buy |
+256
| New | +$566K | ﹤0.01% | 3031 |
|
|
2018
Q2 | – | Sell |
-28
| Closed | -$67K | – | 4170 |
|
|
2018
Q1 | $67K | Sell |
28
-71
| -72% | -$213K | ﹤0.01% | 3517 |
|
|
2017
Q4 | $407K | Sell |
99
-39
| -28% | -$164K | ﹤0.01% | 3196 |
|
|
2017
Q3 | $572K | Sell |
138
-5
| -3% | -$21.4K | ﹤0.01% | 2783 |
|
|
2017
Q2 | $652K | Buy |
143
+77
| +117% | +$326K | ﹤0.01% | 2671 |
|
|
2017
Q1 | $363K | Sell |
66
-60
| -48% | -$279K | ﹤0.01% | 2965 |
|
|
2016
Q4 | $565K | Buy |
+126
| New | +$1.57M | ﹤0.01% | 2624 |
|
|
2016
Q3 | – | Sell |
-47
| Closed | -$712K | – | 3610 |
|
|
2016
Q2 | $712K | Buy |
47
+26
| +124% | +$594K | ﹤0.01% | 2319 |
|
|
2016
Q1 | $576K | Buy |
21
+14
| +200% | +$296K | ﹤0.01% | 2450 |
|
|
2015
Q4 | $189K | Hold |
7
| – | – | ﹤0.01% | 3113 |
|
|
2015
Q3 | $177K | Sell |
7
-17
| -71% | -$1.14M | ﹤0.01% | 3153 |
|
|
2015
Q2 | $1.99M | Buy |
+24
| New | +$2.2M | ﹤0.01% | 1932 |
|
|
2015
Q1 | – | Sell |
-15
| Closed | -$1.99M | – | 4106 |
|
|
2014
Q4 | $1.99M | Buy |
+15
| New | +$1.1M | ﹤0.01% | 1978 |
|
Other funds holding TPST
VVM
DC
Millennium Management's TPST Position: Q1 2025 in Review
Millennium Management sold out of Tempest Therapeutics (TPST) in Q1 2025, closing a stake of 14,577 shares — an estimated $158K sold.
Millennium Management first reported a position in TPST in Q4 2014 and held it in 24 quarters. The position peaked at $1.99M in Q2 2015. 23 funds tracked by Wall St. Rank hold TPST as of Q1 2025.
- Millennium Management reported no remaining Tempest Therapeutics position as of Q1 2025 after selling out during the quarter.
- Millennium Management sold 14,577 Tempest Therapeutics shares in Q1 2025, an estimated $158K.
- Millennium Management first reported a position in Tempest Therapeutics in Q4 2014 and held it in 24 quarters.
- Millennium Management's Tempest Therapeutics position peaked at $1.99M in Q2 2015.
- 23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2025.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.